MicroRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance.
Ontology highlight
ABSTRACT: Over sixty percent of all mammalian protein-coding genes are estimated to be regulated by microRNAs (miRNAs), and unsurprisingly miRNA dysregulation has been linked with cancer. Aberrant miRNA expression in cancer cells has been linked with tumourigenesis and drug resistance. In the past decade, increasing number of studies have demonstrated that cholesterol accumulation fuels tumour growth and contributes to drug resistance, therefore, miRNAs controlling cholesterol metabolism and homeostasis are obvious hypothetical targets for investigating their role in cholesterol-mediated drug resistance in cancer. In this review, we have collated published evidences to consolidate this hypothesis and have scrutinized it by utilizing computational tools to explore the role of miRNAs in cholesterol-me
SUBMITTER: Monchusi B
PROVIDER: S-EPMC7289906 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA